Related Experiment Video
Updated: Feb 25, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells
Weimin Wang1,2, Li Fu2, Shengli Li2
1School of Medicine, Shandong University, Jinan, 250012, China.
Abstract:
The pathogenesis of pituitary tumors (PT) is unclear. Deregulation of apoptosis is one of the factors involving tumor growth. Histone deacetylases (HDAC) have an active role in multiple cellular activities. This study aims to investigate the role of HDAC in the interference with apoptosis in PT. In this study, PT samples were collected from 20 patients after surgery. The expression of HDAC and p53 was analyzed in the PT samples. PT cell line, AtT-20 cells, was cultured to test the role of HDAC in the regulation of apoptosis in PT cells. The results showed that the high levels of HDAC11 and lower levels of p53 were detected in PT. A negative correlation was detected between the data of HDAC11 and p53. A complex of HDAC11 and HEY1, the gene transcription factor of p53, was detected in the PT cells. Less acetylated HEY1 was found in the PT cells. In addition, lower levels of HEY1 and the gene transcription activities were detected at the PT53 promoter locus. This phenomenon was mimicked by overexpression of HDAC11 in AtT-20 cells. Knockdown of HDAC11 enhanced the p53 expression in AtT-20 cells. In conclusion, HDAC11 interferes with p53 expression in PT cells. The fact suggests that inhibition of HDAC11 has therapeutic potential in the treatment of PT.
Insights
Histone deacetylase 11 (HDAC11) interferes with p53 expression in pituitary tumors (PT), promoting tumor growth. Inhibiting HDAC11 may offer a new therapeutic strategy for treating PT.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- The precise mechanisms driving pituitary tumor (PT) pathogenesis remain elusive.
- Disrupted apoptosis is a key contributor to tumor progression.
- Histone deacetylases (HDAC) are critical regulators of cellular processes, including apoptosis.
Purpose of the Study:
- To investigate the role of HDACs in modulating apoptosis within pituitary tumors.
- To explore the specific involvement of HDAC11 in PT development and its relationship with p53.
Main Methods:
- Analysis of HDAC and p53 expression in 20 human PT samples.
- In vitro studies using the AtT-20 pituitary tumor cell line to assess HDAC's impact on apoptosis.
- Detection of protein complexes and analysis of gene transcription activity at the p53 promoter locus.
Main Results:
- Elevated HDAC11 and reduced p53 levels were observed in PT samples, showing a negative correlation.
- HDAC11 formed a complex with HEY1, a p53 transcription factor, leading to decreased HEY1 acetylation and transcriptional activity at the p53 promoter.
- Overexpression of HDAC11 mimicked these effects in AtT-20 cells, while HDAC11 knockdown restored p53 expression.
Conclusions:
- HDAC11 directly interferes with p53 expression in pituitary tumor cells.
- Targeting HDAC11 presents a promising therapeutic avenue for pituitary tumor treatment.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

